SME Times is powered by   
Search News
Just in:   • Govt to buy 10 pc of bonds issued by MSMEs: Minister  • Industrial output contracts 4.3 pc in Sept  • Prime Minister looks inwards for improving governance  • Business confidence down in Aug-Oct: Survey  • Publishing industry to reach $10bn by 2020: BlueRose Publishers founder 
Last updated: 22 Mar, 2019  

Tablet.9.Thmb.jpg World class drugs at affordable prices need of the hour: Naidu

   Top Stories
» Govt to buy 10 pc of bonds issued by MSMEs: Minister
» Industrial output contracts 4.3 pc in Sept
» Business confidence down in Aug-Oct: Survey
» India rising up to assume global leadership position: Naidu
» Goyal to participate in BRICS meet, MSMEs on top agenda
SME Times News Bureau | 21 Mar, 2019

Vice President M. Venkaiah Naidu recently said that world class drugs with unwavering quality at very affordable prices is the need of hour.

Naidu urged the Indian Pharmaceutical industry to remain committed to high standards of quality in drug manufacturing and quality frameworks.

Calling for strict adherence to global standards in manufacturing drugs, he exhorted the industry to earmark more resources for discovering new molecules and new drugs without compromising on the affordability of drugs.

Addressing the 2nd decennial celebrations of Sarojini Naidu Vanita Pharmacy Maha Vidyalaya, in Hyderabad, Naidu stressed the need to give a thrust to research and innovation.

New healthcare challenges are emerging every day, especially with an alarming rise in the number of non communicable and lifestyle diseases and cancers, he added.

The Vice President said that India had become the largest provider of generic drugs globally and in supplying anti-retroviral drugs used worldwide to combat AIDS .

Naidu lauded the yeomen service rendered by Indian companies in providing life saving medicines at affordable prices in the developing countries.

Expressing his desire to see India emerge as the world leader in generic medicines, Shri Naidu wanted the young researchers to also work towards standardizing and benchmarking Indian systems of medicine.

He wanted them to use globally established experimental protocols, to establish the efficiency, validity and efficacy of the traditional medicines.

Naidu asked the Pharma companies to develop new molecules and drugs to combat some of the lesser known diseases, particularly the group of diseases called as “rare diseases”.

Saying that the number of people suffering from rare diseases was estimated to be more than 70 million in India, the Vice President said that it was important for the Indian Pharma industry to look into the need for developing low-cost drugs for treating rare diseases.

Print the Page
Add to Favorite
Share this on :

Please comment on this story:
Subject :
(Maximum 1500 characters)  Characters left 1500
Your name:

  Customs Exchange Rates
Currency Import Export
US Dollar
UK Pound
Japanese Yen 58.85 56.85
As on 12 Nov, 2019
  Daily Poll
Ease of doing business improved in last one year
 Can't say
  Commented Stories
» RBI cuts key rates by 50 basis points(2)
» Appoint distributors, expand your business(1)
» A GeM of opportunity(1)
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter